Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Universal Corporation is a tobacco business based in the US. Universal Corporation shares (UVV) are listed on the NYSE and all prices are listed in US Dollars. Universal Corporation employs 9,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$47.59|
|52-week range||$37.82 - $60.09|
|50-day moving average||$49.40|
|200-day moving average||$54.82|
|Wall St. target price||$59.00|
|Dividend yield||$3.09 (6.46%)|
|Earnings per share (TTM)||$3.50|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-0.69%|
|1 month (2021-08-26)||-3.11%|
|3 months (2021-06-25)||-15.14%|
|6 months (2021-03-26)||-19.39%|
|1 year (2020-09-25)||15.73%|
|2 years (2019-09-26)||-13.22%|
|3 years (2018-09-26)||65.05|
|5 years (2016-09-26)||58.02|
Valuing Universal Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Universal Corporation shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Universal Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $227.9 million.
The EBITDA is a measure of a Universal Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2 billion|
|Operating margin TTM||8.98%|
|Gross profit TTM||$401.7 million|
|Return on assets TTM||5.03%|
|Return on equity TTM||7.12%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
There are currently 475,576 Universal Corporation shares held short by investors – that's known as Universal Corporation's "short interest". This figure is 3.5% up from 459,413 last month.
There are a few different ways that this level of interest in shorting Universal Corporation shares can be evaluated.
Universal Corporation's "short interest ratio" (SIR) is the quantity of Universal Corporation shares currently shorted divided by the average quantity of Universal Corporation shares traded daily (recently around 106631.39013453). Universal Corporation's SIR currently stands at 4.46. In other words for every 100,000 Universal Corporation shares traded daily on the market, roughly 4460 shares are currently held short.
However Universal Corporation's short interest can also be evaluated against the total number of Universal Corporation shares, or, against the total number of tradable Universal Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Universal Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Universal Corporation shares in existence, roughly 20 shares are currently held short) or 0.0196% of the tradable shares (for every 100,000 tradable Universal Corporation shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Universal Corporation.
Find out more about how you can short Universal Corporation stock.
Dividend payout ratio: 90.11% of net profits
Recently Universal Corporation has paid out, on average, around 90.11% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.56% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Universal Corporation shareholders could enjoy a 6.56% return on their shares, in the form of dividend payments. In Universal Corporation's case, that would currently equate to about $3.09 per share.
Universal Corporation's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Universal Corporation's most recent dividend payout was on 31 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 7 October 2021 (the "ex-dividend date").
Universal Corporation's shares were split on a 2:1 basis on 1 January 1992. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Universal Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Universal Corporation shares which in turn could have impacted Universal Corporation's share price.
Over the last 12 months, Universal Corporation's shares have ranged in value from as little as $37.8237 up to $60.0943. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Universal Corporation's is 0.6949. This would suggest that Universal Corporation's shares are less volatile than average (for this exchange).
Universal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. The company contracts, purchases, processes, and sells flue-cured, burley, and oriental tobaccos that are primarily used in the manufacture of cigarettes; and dark air-cured tobaccos principally used in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products. It also provides value-added services, including blending, chemical, and physical testing of tobacco; service cutting for various manufacturers; manufacturing reconstituted leaf tobacco; just-in-time inventory management services; electronic nicotine delivery systems; and smoke testing services for customers. In addition, the company offers testing services for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors; and analytical services that include chemical compound testing in finished tobacco products and mainstream smoke. Further, it provides a various value-added manufacturing processes to produce specialty vegetable and fruit-based ingredients for the food and beverage end markets, as well as provides water pipe style leaf tobacco; and recycles waste materials from tobacco production.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.